Bill Text: TX HB2079 | 2023-2024 | 88th Legislature | Introduced


Bill Title: Relating to the authority of pharmacists to order and furnish certain prescription drugs.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2023-04-17 - Left pending in committee [HB2079 Detail]

Download: Texas-2023-HB2079-Introduced.html
 
 
  By: Jetton H.B. No. 2079
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the authority of pharmacists to order and furnish
  certain prescription drugs.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 483.001(11), Health and Safety Code, is
  amended to read as follows:
               (11)  "Practice of pharmacy" has the meaning assigned
  by Section 551.003, Occupations Code [means:
                     [(A)  provision of those acts or services
  necessary to provide pharmaceutical care;
                     [(B)  interpretation and evaluation of
  prescription drug orders or medication orders;
                     [(C)  participation in drug and device selection
  as authorized by law, drug administration, drug regimen review, or
  drug or drug-related research;
                     [(D)  provision of patient counseling;
                     [(E)  responsibility for:
                           [(i)  dispensing of prescription drug orders
  or distribution of medication orders in the patient's best
  interest;
                           [(ii)  compounding and labeling of drugs and
  devices, except labeling by a manufacturer, repackager, or
  distributor of nonprescription drugs and commercially packaged
  prescription drugs and devices;
                           [(iii)  proper and safe storage of drugs and
  devices; or
                           [(iv)  maintenance of proper records for
  drugs and devices. In this subdivision, "device" has the meaning
  assigned by Subtitle J, Title 3, Occupations Code; or
                     [(F)  performance of a specific act of drug
  therapy management for a patient delegated to a pharmacist by a
  written protocol from a physician licensed by the state under
  Subtitle B, Title 3, Occupations Code].
         SECTION 2.  Section 551.003(33), Occupations Code, is
  amended to read as follows:
               (33)  "Practice of pharmacy" means:
                     (A)  providing an act or service necessary to
  provide pharmaceutical care;
                     (B)  interpreting or evaluating a prescription
  drug order or medication order;
                     (C)  participating in drug or device selection as
  authorized by law, and participating in drug administration, drug
  regimen review, or drug or drug-related research;
                     (D)  providing patient counseling;
                     (E)  being responsible for:
                           (i)  dispensing a prescription drug order or
  distributing a medication order;
                           (ii)  compounding or labeling a drug or
  device, other than labeling by a manufacturer, repackager, or
  distributor of a nonprescription drug or commercially packaged
  prescription drug or device;
                           (iii)  properly and safely storing a drug or
  device; or
                           (iv)  maintaining proper records for a drug
  or device;
                     (F)  performing for a patient a specific act of
  drug therapy management delegated to a pharmacist by a written
  protocol from a physician licensed in this state in compliance with
  Subtitle B; [or]
                     (G)  administering an immunization or vaccination
  under a physician's written protocol; or
                     (H)  ordering or furnishing a prescription drug to
  treat an acute condition in accordance with Section 562.058.
         SECTION 3.  Subchapter B, Chapter 562, Occupations Code, is
  amended by adding Section 562.058 to read as follows:
         Sec. 562.058.  ORDERING AND FURNISHING CERTAIN PRESCRIPTION
  DRUGS. (a) In this section:
               (1)  "Acute condition" means a condition or disease
  that begins abruptly, intensifies rapidly, and is generally not
  long-lasting.
               (2)  "Waived clinical laboratory test" means a clinical
  laboratory test that is classified as waived under federal
  regulations issued under the Clinical Laboratory Improvement
  Amendments of 1988 (42 U.S.C. Section 263a).
         (b)  Notwithstanding any other law, a pharmacist may order
  and furnish to a patient a prescription drug to treat an acute
  condition that is identified through performance of one of the
  following tests, if the test is a waived clinical laboratory test:
               (1)  a rapid strep test or rapid antigen detection test
  used in the identification of group A streptococcus (GAS);
               (2)  a rapid influenza diagnostic test used in the
  identification of influenza types A and B; or
               (3)  a rapid diagnostic test for SARS-CoV-2 or a
  related virus used in the identification of COVID-19 or a related
  illness.
         (c)  The board shall adopt rules to permit a pharmacist to
  order and furnish a prescription drug under this section to a
  patient without an established physician-patient relationship.
         (d)  A pharmacist who orders and furnishes a prescription
  drug under this section must provide notice to the patient's
  primary care physician, as identified by the patient if the patient
  has a primary care physician, not later than the 14th day after the
  date the drug is ordered and furnished by the pharmacist.
         (e)  The board by rule shall establish requirements to ensure
  that a pharmacist possesses the necessary skill and training to
  order and furnish prescription drugs under this section.
         SECTION 4.  Not later than January 1, 2024, the Texas State
  Board of Pharmacy shall adopt the rules required under Section
  562.058, Occupations Code, as added by this Act.
         SECTION 5.  This Act takes effect September 1, 2023.
feedback